Centre intégré de cancérologie du CHU de Québec Université L-Hemato-Oncology ( Site 1101)

Québec, Quebec G1J 1Z4

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001) — Running, not enrolling